Relay Therapeutics (RLAY)
Designs small-molecule medicines around protein motion for cancer and genetic disease.
$19.08
vs last close+0.89 (+4.89%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 112.41% | 246.34M shares | |
|---|---|---|---|
| 270 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.84% | 1.84M shares | |
| 5 holders · as of Sep 9, 2026 | |||
| Strategic holders | 10.00% | 21.90M shares | |
| 1 holder · as of Aug 28, 2026 | |||
| Adds to | 123.25% | ||
219.14M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
These groups come from separate filings that can overlap, so they add to 123.25%; nothing is left for Other.
13F, as of Jun 30, 2026
270 holders · 246.34M shares · 54 new positions · 170 increased · 64 reduced · 35 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| SB Investment Advisers (UK) Ltd | 27.90M | 12.73% | 0 | Aug 14, 2026 |
| FMR LLC | 20.11M | 9.18% | +16.41M | Aug 13, 2026 |
| Casdin Capital, LLC | 16.04M | 7.32% | +1.62M | Aug 14, 2026 |
| BlackRock, Inc. | 15.29M | 6.98% | +2.31M | Aug 7, 2026 |
| Perceptive Advisors LLC | 14.11M | 6.44% | +4.36M | Aug 14, 2026 |
| Commodore Capital LP | 12.00M | 5.48% | −5.00M | Aug 14, 2026 |
| State Street Corp | 10.13M | 4.62% | +3.89M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 8.96M | 4.09% | +1.58M | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Perceptive Advisors LLC | 9.99% | 13G | Apr 13, 2026 | |
| Commodore Capital LP | 9.90% | 17.00M | 13G | Nov 14, 2025 |
| Casdin Capital, LLC | 7.50% | 13.00M | 13G | Feb 17, 2026 |
| BlackRock, Inc. | 6.10% | 10.31M | 13G | Apr 17, 2025 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 8, 2026 | Sanjiv Pateldirector, officer: President and CEO | Sale | 48,199 | $18.94 | 519,500 |
| Sep 8, 2026 | Thomas Catinazzoofficer: Chief Financial Officer | Sale | 17,717 | $18.94 | 122,851 |
| Sep 8, 2026 | Donald A. Bergstromofficer: President, R&D | Sale | 8,530 | $18.97 | 399,130 |
| Aug 26, 2026 | Peter Rahmerofficer: See remarks | Sale | 4,508 | $20.03 | 223,657 |
| Aug 25, 2026 | SVF Pauling (Cayman) Ltd10 percent owner | Sale | 6,000,000 | $19.40 | 21,904,963 |
| Aug 14, 2026 | Thomas Catinazzoofficer: Chief Financial Officer | Sale | 17,717 | $19.74 | 140,568 |
| Aug 17, 2026 | Sanjiv Pateldirector, officer: President and CEO | Sale | 48,199 | $20.33 | 567,699 |
| Jul 28, 2026 | Donald A. Bergstromofficer: President, R&D | Sale | 2,237 | $18.61 | 407,660 |
| Jul 28, 2026 | Peter Rahmerofficer: See remarks | Sale | 748 | $18.61 | 228,165 |
| Jul 28, 2026 | Thomas Catinazzoofficer: Chief Financial Officer | Sale | 1,459 | $18.61 | 158,285 |
House and Senate disclosures
Not reported.